VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tom pope	5/28/2014 12:31:43 PM
	Read Replies (1) of 23519

Aspen Investment Fund LLC is considering a nonbinding offer worth $640 million for Vivus Inc., VVUS +6.78% potentially starting a new battle for control of the pharmaceutical firm. The private investment fund, which disclosed a 9.65% stake in Vivus, called the company's shares undervalued in a filing with the U.S. Securities and Exchange Commission. Aspen Investment said it hopes to engage in discussion with Vivus's board and management and indicated any preliminary bid would be submitted by June 13. A Vivus spokesman didn't have an immediate comment, and a representative from Aspen Investment wasn't available. The new stake makes Aspen the largest investor in Vivus. From the stock action, the market doesn't seem to believe the full amount of the offer is actually there.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next